|
|
| | N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine Basic information |
| | N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine Chemical Properties |
| Boiling point | 553.5±58.0 °C(Predicted) | | density | 1.32±0.1 g/cm3(Predicted) | | solubility | DMSO (Slightly, Heated), Methanol (Slightly) | | pka | 6.48±0.10(Predicted) | | form | Solid | | color | White to Light Yellow |
| | N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine Usage And Synthesis |
| Uses | N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine is a degredation product of Pazopanib (P210925), an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
| | N4-(2,3-Dimethyl-2H-indazol-6-yl)-N4-methyl-2,4-pyrimidinediamine Preparation Products And Raw materials |
|